About
Compounds Targeting Glymphatic System
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
49
By Phase
NA: 2
By Status
COMPLETED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
Today
Hover over trial bars to see details
Recent Trials
NCT06222385Lead Sponsor
Applied Cognition Benchmarking Study
NACompleted
34 participants
Started: Nov 7, 2022 · Completed: Jun 8, 2023
NCT06060054Lead Sponsor
Continuous Measurement of Glymphatic Activity in the Human Brain During Sleep-Wake States
NACompleted
15 participants
Started: Nov 1, 2022 · Completed: May 10, 2023
Funding History (1)
D
Dec 2, 2021
Locations (1)
Headquarters
Redwood City, CA, United States
Map
Loading map...